e-Therapeutics plc (ETX) Ordinary 0.1p
Share news, reports & tips
12 April 2022 13:26
(Sharecast News) - Drug discovery specialist E-therapeutics announced on Tuesday that it has reached a key milestone in its collaboration with Galapagos.
22 November 2021 14:16
(Sharecast News) - Drug discovery company E-therapeutics announced on Monday that Karl Keegan was stepping down from his non-board role as chief financial officer, to focus on "extremely difficult"...
22 November 2021 10:20
(Sharecast News) - Drug discovery e-Therapeutics revealed on Monday that chief financial officer Karl Keegan will step down from the role in order to focus on "extremely difficult family...
2 July 2021 13:47
(Sharecast News) - E-therapeutics has met a key milestone in its collaboration with Galapagos, a commercial-stage company specialising in the discovery and development of small-molecule medicines with novel...
2 June 2021 09:42
(Sharecast News) - Drug discovery company e-therapeutics announced the appointment of Alison Gallafent as its head of intellectual property on Wednesday.
14 May 2021 14:20
(Sharecast News) - E-therapeutics has completed a placing, subscription and retail offer via PrimaryBid, it announced on Friday, conditionally raising gross proceeds of £22.5m to help expand its drug...
23 April 2021 10:18
(Sharecast News) - E-therapeutics has met two key milestones in its collaboration with small-molecule medicines specialist Galapagos, it announced on Friday.
12 October 2020 10:06
(Sharecast News) - Drug discovery and development company e-Therapeutics said on Monday that it was feeling "re-energised" by the addition of former Silence Therapeutics boss Ali Mortazavi amid...
10 June 2020 09:20
(Sharecast News) - E-therapeutics has entered a collaboration agreement with Galapagos to identify new therapeutic approaches to modulate a specific mechanism involved in idiopathic pulmonary fibrosis (IPF),...
13 August 2019 10:35
(Sharecast News) - E-therapeutics announced an agreement to work with an unnamed "global top five pharmaceutical company" on Tuesday, on a project in a specific area of biology associated with...
Company announcements Announcements
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2022. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.